Ponatinib HCl CAS NO.1114544-31-8

Topbatt Chemical Co., Ltd., Established in 2019, located in Shenzhen, Guangdong Province, is a Manufacturer and Trading company which specialized in fine chemicals like Pharmaceutical Reference Standards, Stable Isotopes, API and intermediates.

We own a number of Senior pharmaceutical synthetic engineer, analysis engineer and analytical testing instrument. It makes us have more than 1700 varieties compounds with high purity in stock in a short time.

We can provide you not only stock items, but also Custom Synthesis Service. All of our products provided with COA, HPLC/GC, NMR, MS Spectrum.

Contact us for more details, 24/7 stand by for you. After-sales issues will be settled in 24 hours.

Product Name: Ponatinib

Purity: 99%

Price: Negotiable

Ponatinib is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.

We have been producing this API for about 3 years regularly and selling well all the time. We can offer package from 100g to 5kg or even bigger, it depends on clients.

Our manufacturing process has been developed very well and the cost is low, so our price is good and the quality is still good and stable.